Publications by authors named "F Villetard"

Claim this Profile
L
Long-Term Outcomes and Management Strategies With DA-R-EPOCH in Primary Mediastinal B-Cell Lymphoma: Insights From a Single-Center Experience.
Robin Noel, Catalina Montes de Oca, Patrick Sfumato, Anne Calleja, Aude Collignon, Ferdinand Villetard

Hematol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognosis of SRSF2 gene mutations in patients treated with VEN-AZA for newly diagnosed acute myeloid leukemia.
Guillaume Berton, Bochra Sedaki, Erwann Collomb, Sami Benachour, Michael Loschi, Ferdinand Villetard

Leuk Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
C Petit, C Saillard, B Mohty, Y Hicheri, F Villetard

Eur J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, Colombe Saillard, Yosr Hicheri, Ferdinand Villetard

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis